Safe injection sites — also called supervised consumption facilities — allow people to use pre-obtained illegal drugs under medical supervision with naloxone available to reverse overdoses. Proponents cite them as life-saving harm reduction. The reality is considerably more complicated.

The most frequently cited evidence comes from Insite, the safe injection facility operating in Vancouver, Canada since 2003. A study published in The Lancet found that Insite had not recorded a single overdose death on-site in its years of operation. However, a broader analysis of the surrounding neighborhood told a different story. Research from Simon Fraser University found no significant reduction in overdose deaths in the area surrounding Insite compared to other parts of Vancouver. The facility appeared to prevent deaths inside its walls while the broader crisis continued to worsen.

The New York City safe injection sites (OnPoint NYC), opened in 2021, have reported similar patterns — no on-site deaths but continued high overdose rates in surrounding areas. A 2023 analysis found that only about 1% of visits to the NYC sites resulted in referrals to treatment. This is a critical data point: if safe injection sites are supposed to be a gateway to recovery, the gateway is barely open.

Community impact is a significant concern that harm reduction advocates often dismiss. Research from Australia, where the Sydney Medically Supervised Injecting Centre has operated since 2001, documented increases in publicly discarded needles, drug-related loitering, and property crime in the immediate vicinity. Businesses and residents near these facilities consistently report quality-of-life declines.

The philosophical issue is equally important. Safe injection sites implicitly accept that ongoing drug addiction is a permanent state to be managed rather than a condition that can be overcome. They consume public resources that could fund treatment beds, medication-assisted treatment, and recovery services — interventions that actually help people leave addiction behind. The U.S. has a severe shortage of treatment capacity: SAMHSA estimates that only 1 in 10 people with substance use disorders receives treatment.

A society that makes it easier and safer to use drugs while failing to adequately fund treatment is not practicing compassion — it's practicing managed decline. The genuinely compassionate approach is investing in robust treatment infrastructure that offers people a path out of addiction, not a more comfortable place to remain in it.